欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/2590/001
药品名称	IBU-LYSIN-ratiopharm
活性成分	ibuprofen lysin salt 684.0 mg
剂型	Film-coated tablet
上市许可持有人	ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
参考成员国 - 产品名称	Germany (DE) IBU-ratiopharm Lysinat 684 mg Filmtabletten
互认成员国 - 产品名称	Luxembourg (LU) Austria (AT) ratioDolor akut 400 mg Filmtabletten Finland (FI)
许可日期	2011/05/05
最近更新日期	2024/02/01
药物ATC编码	M01AE01 ibuprofen
申请类型	TypeLevel1：Abridged TypeLevel2：Multiple (Copy) Application TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Non Prescription (including OTC)
附件文件下载	Final SPC \| DE_2590_1_WS_1457_Ibuprofen_FINAL_SmPC_cleanDate of last change:2024/02/01 Final PL \| DE_2590_1_WS_1457_Ibuprofen_FINAL_PIL_cleanDate of last change:2024/02/01 Final Product Information \| final-common-IP.2590-025Date of last change:2021/04/22 Final Product Information \| final-common-PL.2590-025Date of last change:2021/04/22 Final Product Information \| final-common-OP.2590-025Date of last change:2021/04/22 Final Product Information \| final-common-SPC.2590-025Date of last change:2021/04/22 Final Labelling \| common-final-labop-2590-V019Date of last change:2018/05/29 PAR \| PAREN-DE2589-2593_IbuprofenDate of last change:2014/02/26
市场状态	Positive